O	O	O	0	9	Inducible	Inducible	B-NP	JJ	O	3	NMOD	O
O	O	O	10	16	nitric	nitric	I-NP	JJ	O	3	NMOD	O
O	O	O	17	22	oxide	oxide	I-NP	NN	O	8	NMOD	O
O	O	O	22	23	:	:	O	:	O	3	P	O
O	O	O	24	26	an	an	B-NP	DT	O	8	NMOD	O
O	O	O	27	41	autoregulatory	autoregulatory	I-NP	JJ	O	8	NMOD	O
O	O	O	42	50	feedback	feedback	I-NP	NN	O	8	NMOD	O
O	O	O	51	60	inhibitor	inhibitor	I-NP	NN	O	0	ROOT	O
O	O	O	61	63	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	64	72	vascular	vascular	B-NP	JJ	O	11	NMOD	O
O	O	O	73	85	inflammation	inflammation	I-NP	NN	O	9	PMOD	O
O	O	O	85	86	.	.	O	.	O	8	P	O

O	O	O	88	97	Inducible	Inducible	B-NP	JJ	O	3	NMOD	O
O	O	O	98	104	nitric	nitric	I-NP	JJ	O	3	NMOD	O
O	O	O	105	110	oxide	oxide	I-NP	NN	O	7	SUB	O
O	O	O	111	112	(	(	O	(	O	6	DEP	O
O	O	O	112	115	iNO	iNO	B-NP	NN	B-protein	6	DEP	B-protein
O	O	O	115	116	)	)	O	)	O	3	NMOD	O
O	O	O	117	119	is	be	B-VP	VBZ	O	29	VMOD	O
O	O	O	120	128	produced	produce	I-VP	VBN	O	7	VC	O
O	O	O	129	131	at	at	B-PP	IN	O	8	VMOD	O
O	O	O	132	137	sites	site	B-NP	NNS	O	9	PMOD	O
O	O	O	138	140	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	141	149	vascular	vascular	B-NP	JJ	O	13	NMOD	O
O	O	O	150	162	inflammation	inflammation	I-NP	NN	O	11	PMOD	O
O	O	O	163	165	by	by	B-PP	IN	O	8	VMOD	O
O	O	O	166	174	resident	resident	B-NP	JJ	O	17	AMOD	O
O	O	O	175	178	and	and	I-NP	CC	O	17	AMOD	O
O	O	O	179	190	nonresident	nonresident	I-NP	JJ	O	20	NMOD	O
O	O	O	191	199	vascular	vascular	I-NP	JJ	B-cell_type	20	NMOD	B-cell_type
O	O	O	200	204	wall	wall	I-NP	NN	I-cell_type	20	NMOD	I-cell_type
O	O	O	205	210	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	O	210	211	,	,	O	,	O	29	P	O
O	O	O	212	215	but	but	O	CC	O	24	NMOD	O
O	O	O	216	219	its	its	B-NP	PRP$	O	24	NMOD	O
O	O	O	220	224	role	role	I-NP	NN	O	29	SUB	O
O	O	O	225	227	in	in	B-PP	IN	O	24	NMOD	O
O	O	O	228	231	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	232	244	inflammatory	inflammatory	I-NP	JJ	O	28	NMOD	O
O	O	O	245	252	process	process	I-NP	NN	O	25	PMOD	O
O	O	O	253	255	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	256	259	not	not	I-VP	RB	O	29	VMOD	O
O	O	O	260	265	known	know	I-VP	VBN	O	29	VC	O
O	O	O	265	266	.	.	O	.	O	29	P	O

O	O	O	267	269	In	In	B-PP	IN	O	6	VMOD	O
O	O	O	270	274	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	275	280	study	study	I-NP	NN	O	1	PMOD	O
O	O	O	280	281	,	,	O	,	O	6	P	O
O	O	O	282	284	we	we	B-NP	PRP	O	6	SUB	O
O	O	O	285	289	show	show	B-VP	VBP	O	0	ROOT	O
O	O	O	290	294	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	O	295	296	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	297	302	novel	novel	I-NP	JJ	O	10	NMOD	O
O	O	O	303	311	function	function	I-NP	NN	O	13	SUB	O
O	O	O	312	314	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	315	318	iNO	iNO	B-NP	NN	B-protein	11	PMOD	B-protein
O	O	O	319	321	is	be	B-VP	VBZ	O	7	SBAR	O
O	O	O	322	324	to	to	B-VP	TO	O	15	VMOD	O
O	O	O	325	334	terminate	terminate	I-VP	VB	O	13	PRD	O
O	O	O	335	347	inflammatory	inflammatory	B-NP	JJ	O	17	NMOD	O
O	O	O	348	357	processes	process	I-NP	NNS	O	15	OBJ	O
O	O	O	357	358	.	.	O	.	O	6	P	O

O	O	O	359	361	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	362	366	find	find	B-VP	VBP	O	0	ROOT	O
O	O	O	367	371	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	372	375	iNO	iNO	B-NP	NN	B-protein	17	SUB	B-protein
O	O	O	376	384	produced	produce	B-VP	VBN	O	4	NMOD	O
O	O	O	385	387	by	by	B-PP	IN	O	5	VMOD	O
O	O	O	388	394	murine	murine	B-NP	JJ	B-cell_line	11	NMOD	B-cell_line
O	O	O	395	405	macrophage	macrophage	I-NP	NN	I-cell_line	11	NMOD	I-cell_line
O	O	O	405	406	-	-	B-NP	HYPH	I-cell_line	11	NMOD	I-cell_line
O	O	O	406	410	like	like	I-NP	JJ	I-cell_line	11	NMOD	I-cell_line
O	O	O	411	416	cells	cell	I-NP	NNS	I-cell_line	15	NMOD	I-cell_line
O	O	O	416	417	,	,	O	,	O	15	P	O
O	O	O	418	424	RAW264	RAW264	B-NP	NN	B-cell_line	15	NMOD	B-cell_line
O	O	O	424	425	.	.	I-NP	.	I-cell_line	13	P	I-cell_line
O	O	O	425	426	7	7	I-NP	CD	I-cell_line	6	PMOD	I-cell_line
O	O	O	426	427	,	,	O	,	O	15	P	O
O	O	O	428	431	can	can	B-VP	MD	O	3	SBAR	O
O	O	O	432	439	inhibit	inhibit	I-VP	VB	O	17	VC	O
O	O	O	440	448	cytokine	cytokine	B-NP	NN	B-protein	21	AMOD	B-protein
O	O	O	448	449	-	-	O	HYPH	O	19	P	O
O	O	O	449	456	induced	induce	B-NP	VBN	O	24	NMOD	O
O	O	O	457	468	endothelial	endothelial	I-NP	JJ	O	24	NMOD	O
O	O	O	469	473	cell	cell	I-NP	NN	O	24	NMOD	O
O	O	O	474	484	activation	activation	I-NP	NN	O	18	OBJ	O
O	O	O	485	487	in	in	B-PP	IN	O	18	VMOD	O
O	O	O	488	489	a	a	B-NP	DT	O	32	NMOD	O
O	O	O	490	499	separated	separate	I-NP	VBN	O	29	AMOD	O
O	O	O	500	503	and	and	I-NP	CC	O	29	AMOD	O
O	O	O	504	509	mixed	mix	I-NP	VBN	O	32	NMOD	O
O	O	O	510	521	endothelial	endothelial	I-NP	JJ	O	32	NMOD	O
O	O	O	521	522	-	-	I-NP	HYPH	O	32	NMOD	O
O	O	O	522	528	RAW264	RAW264	I-NP	NN	B-protein	25	PMOD	B-protein
O	O	O	528	529	.	.	O	.	O	2	P	O
O	O	O	529	530	7	7	B-NP	CD	O	36	NMOD	O
O	O	O	531	540	coculture	coculture	I-NP	NN	O	36	NMOD	O
O	O	O	541	547	system	system	I-NP	NN	O	2	VMOD	O
O	O	O	547	548	.	.	O	.	O	2	P	O

O	O	O	549	553	Both	Both	O	CC	O	9	NMOD	O
O	O	O	554	557	iNO	iNO	B-NP	NN	O	3	NMOD	O
O	O	O	558	568	production	production	I-NP	NN	O	9	NMOD	O
O	O	O	569	572	and	and	O	CC	O	9	NMOD	O
O	O	O	573	584	endothelial	endothelial	B-NP	JJ	O	9	NMOD	O
T1	B-Protein	B-Protein	585	589	VCAM	VCAM	I-NP	NN	B-protein	9	NMOD	B-protein
T1	I-Protein	I-Protein	589	590	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T1	I-Protein	I-Protein	590	591	1	1	I-NP	CD	I-protein	9	NMOD	I-protein
O	O	O	592	602	expression	expression	I-NP	NN	O	10	SUB	O
O	O	O	603	607	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	608	615	induced	induce	I-VP	VBN	O	10	VC	O
O	O	O	616	630	simultaneously	simultaneously	B-ADVP	RB	O	11	VMOD	O
O	O	O	631	635	with	with	B-PP	IN	O	11	VMOD	O
O	O	O	636	645	bacterial	bacterial	B-NP	JJ	O	15	NMOD	O
O	O	O	646	649	LPS	LPS	I-NP	NN	O	22	NMOD	O
O	O	O	650	653	and	and	O	CC	O	22	NMOD	O
O	O	O	654	660	murine	murine	B-NP	JJ	O	19	AMOD	O
O	O	O	660	661	-	-	I-NP	HYPH	O	17	P	O
O	O	O	661	669	specific	specific	I-NP	JJ	O	22	NMOD	O
T2	B-Protein	B-Protein	670	673	IFN	IFN	I-NP	NN	B-protein	22	NMOD	B-protein
T2	I-Protein	I-Protein	673	674	-	-	I-NP	HYPH	I-protein	22	NMOD	I-protein
T2	I-Protein	I-Protein	674	679	gamma	gamma	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	679	680	.	.	O	.	O	10	P	O

O	O	O	681	691	Inhibition	Inhibition	B-NP	NN	O	24	NMOD	O
O	O	O	692	694	of	of	B-PP	IN	O	1	NMOD	O
T3	B-Protein	B-Protein	695	698	iNO	iNO	B-NP	NN	B-protein	4	NMOD	B-protein
T3	I-Protein	I-Protein	699	707	synthase	synthase	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	O	708	709	(	(	O	(	O	7	DEP	O
T4	B-Protein	B-Protein	709	713	iNOS	iNOS	B-NP	NN	B-protein	7	DEP	B-protein
O	O	O	713	714	)	)	O	)	O	4	NMOD	O
O	O	O	715	723	activity	activity	B-NP	NN	O	2	PMOD	O
O	O	O	724	728	with	with	B-PP	IN	O	8	NMOD	O
T13	B-Entity	B-Entity	729	730	N	N	B-NP	NN	O	17	NMOD	O
T13	I-Entity	I-Entity	731	736	omega	omega	B-VP	SYM	O	17	NMOD	O
T13	I-Entity	I-Entity	736	737	-	-	B-NP	HYPH	O	17	NMOD	O
T13	I-Entity	I-Entity	737	747	monomethyl	monomethyl	I-NP	NN	O	17	NMOD	O
T13	I-Entity	I-Entity	747	748	-	-	B-NP	HYPH	O	17	NMOD	O
T13	I-Entity	I-Entity	748	749	L	L	I-NP	NN	O	17	NMOD	O
T13	I-Entity	I-Entity	749	750	-	-	B-NP	HYPH	O	17	NMOD	O
T13	I-Entity	I-Entity	750	758	arginine	arginine	I-NP	NN	O	9	PMOD	O
O	O	O	759	761	in	in	B-PP	IN	O	17	NMOD	O
O	O	O	762	773	endothelial	endothelial	B-NP	JJ	O	21	NMOD	O
O	O	O	773	774	-	-	I-NP	HYPH	O	21	P	O
O	O	O	774	780	RAW264	RAW264	I-NP	NN	B-cell_line	18	PMOD	B-cell_line
O	O	O	780	781	.	.	O	.	I-cell_line	1	P	I-cell_line
O	O	O	781	782	7	7	B-NP	CD	I-cell_line	24	NMOD	I-cell_line
O	O	O	783	793	cocultures	coculture	I-NP	NNS	I-cell_line	37	SUB	I-cell_line
O	O	O	793	794	,	,	O	,	O	24	P	O
O	O	O	795	805	stimulated	stimulate	B-VP	VBN	O	24	NMOD	O
O	O	O	806	810	with	with	B-PP	IN	O	26	VMOD	O
O	O	O	811	817	murine	murine	B-NP	JJ	O	35	NMOD	O
O	O	O	817	818	-	-	I-NP	HYPH	O	35	NMOD	O
O	O	O	818	826	specific	specific	I-NP	JJ	O	35	NMOD	O
T5	B-Protein	B-Protein	827	830	IFN	IFN	I-NP	NN	B-protein	35	NMOD	B-protein
T5	I-Protein	I-Protein	830	831	-	-	O	HYPH	O	35	P	O
T5	I-Protein	I-Protein	831	836	gamma	gamma	B-NP	SYM	O	35	NMOD	O
O	O	O	837	840	and	and	O	CC	O	35	NMOD	O
O	O	O	841	844	LPS	LPS	B-NP	NN	O	27	PMOD	O
O	O	O	844	845	,	,	O	,	O	24	P	O
O	O	O	846	855	decreased	decrease	B-VP	VBD	O	0	ROOT	O
O	O	O	856	859	iNO	iNO	B-NP	NN	B-protein	39	NMOD	B-protein
O	O	O	860	870	production	production	I-NP	NN	O	37	OBJ	O
O	O	O	871	873	by	by	B-PP	IN	O	37	VMOD	O
O	O	O	874	876	86	86	B-NP	CD	O	42	NMOD	O
O	O	O	876	877	%	%	I-NP	NN	O	40	PMOD	O
O	O	O	877	878	,	,	O	,	O	37	P	O
O	O	O	879	888	augmented	augment	B-VP	VBD	O	37	VMOD	O
T6	B-Protein	B-Protein	889	893	VCAM	VCAM	B-NP	NN	B-protein	50	NMOD	B-protein
T6	I-Protein	I-Protein	893	894	-	-	B-NP	HYPH	O	50	NMOD	O
T6	I-Protein	I-Protein	894	895	1	1	I-NP	CD	O	50	NMOD	O
O	O	O	896	899	and	and	O	CC	O	50	NMOD	O
T7	B-Protein	B-Protein	900	904	iNOS	iNOS	B-NP	NN	B-protein	50	NMOD	B-protein
O	O	O	905	915	expression	expression	I-NP	NN	O	44	OBJ	O
O	O	O	916	918	in	in	B-PP	IN	O	44	VMOD	O
O	O	O	919	930	endothelial	endothelial	B-NP	JJ	O	51	PMOD	O
O	O	O	931	934	and	and	I-NP	CC	O	54	NMOD	O
O	O	O	935	941	RAW264	RAW264	I-NP	NN	B-cell_line	52	NMOD	B-cell_line
O	O	O	941	942	.	.	O	.	I-cell_line	37	P	I-cell_line
O	O	O	942	943	7	7	B-NP	CD	I-cell_line	57	NMOD	I-cell_line
O	O	O	944	949	cells	cell	I-NP	NNS	I-cell_line	37	OBJ	I-cell_line
O	O	O	949	950	,	,	O	,	O	57	P	O
O	O	O	951	963	respectively	respectively	B-ADVP	RB	O	57	NMOD	O
O	O	O	963	964	,	,	O	,	O	37	P	O
O	O	O	965	968	and	and	O	CC	O	37	VMOD	O
O	O	O	969	978	increased	increase	B-VP	VBD	O	37	VMOD	O
O	O	O	979	987	monocyte	monocyte	B-NP	NN	O	64	NMOD	O
O	O	O	988	996	adhesion	adhesion	I-NP	NN	O	62	OBJ	O
O	O	O	997	999	to	to	B-PP	TO	O	64	NMOD	O
O	O	O	1000	1003	the	the	B-NP	DT	O	69	NMOD	O
O	O	O	1004	1015	endothelial	endothelial	I-NP	JJ	O	69	NMOD	O
O	O	O	1016	1020	cell	cell	I-NP	NN	O	69	NMOD	O
O	O	O	1021	1028	surface	surface	I-NP	NN	O	65	PMOD	O
O	O	O	1028	1029	.	.	O	.	O	37	P	O

O	O	O	1030	1039	Transient	Transient	B-NP	JJ	O	3	NMOD	O
O	O	O	1040	1052	transfection	transfection	I-NP	NN	O	3	NMOD	O
O	O	O	1053	1060	studies	study	I-NP	NNS	O	11	SUB	O
O	O	O	1061	1066	using	use	B-VP	VBG	O	3	NMOD	O
O	O	O	1067	1074	various	various	B-NP	JJ	O	4	OBJ	O
T8	B-Protein	B-Protein	1075	1079	VCAM	VCAM	I-NP	NN	B-protein	5	NMOD	B-protein
T8	I-Protein	I-Protein	1079	1080	-	-	I-NP	HYPH	O	5	P	O
T8	I-Protein	I-Protein	1080	1081	1	1	I-NP	CD	B-DNA	10	NMOD	B-DNA
O	O	O	1082	1090	promoter	promoter	I-NP	NN	I-DNA	10	NMOD	I-DNA
O	O	O	1091	1101	constructs	construct	I-NP	NNS	I-DNA	5	NMOD	I-DNA
O	O	O	1102	1114	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	O	1115	1119	that	that	B-SBAR	IN	O	11	VMOD	O
O	O	O	1120	1130	inhibitory	inhibitory	B-NP	JJ	O	14	NMOD	O
O	O	O	1131	1138	effects	effect	I-NP	NNS	O	23	SUB	O
O	O	O	1139	1141	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	1142	1145	iNO	iNO	B-NP	NN	O	15	PMOD	O
O	O	O	1146	1148	on	on	B-PP	IN	O	14	NMOD	O
T9	B-Protein	B-Protein	1149	1153	VCAM	VCAM	B-NP	NN	B-protein	22	NMOD	B-protein
T9	I-Protein	I-Protein	1153	1154	-	-	B-NP	HYPH	O	22	NMOD	O
T9	I-Protein	I-Protein	1154	1155	1	1	I-NP	CD	O	22	NMOD	O
O	O	O	1156	1160	gene	gene	I-NP	NN	O	22	NMOD	O
O	O	O	1161	1174	transcription	transcription	I-NP	NN	O	17	PMOD	O
O	O	O	1175	1179	were	be	B-VP	VBD	O	12	SBAR	O
O	O	O	1180	1188	mediated	mediate	I-VP	VBN	O	23	VC	O
O	O	O	1188	1189	,	,	O	,	O	24	P	O
O	O	O	1190	1192	in	in	B-PP	IN	O	24	VMOD	O
O	O	O	1193	1197	part	part	B-NP	NN	O	26	PMOD	O
O	O	O	1197	1198	,	,	O	,	O	24	P	O
O	O	O	1199	1201	by	by	B-PP	IN	O	24	VMOD	O
O	O	O	1202	1212	inhibitory	inhibitory	B-NP	JJ	O	31	NMOD	O
O	O	O	1213	1220	effects	effect	I-NP	NNS	O	29	PMOD	O
O	O	O	1221	1223	of	of	B-PP	IN	O	31	NMOD	O
O	O	O	1224	1227	iNO	iNO	B-NP	NN	O	32	PMOD	O
O	O	O	1228	1230	on	on	B-PP	IN	O	31	NMOD	O
T14	B-Entity	B-Entity	1231	1236	kappa	kappa	B-NP	NN	B-DNA	37	NMOD	B-DNA
T14	I-Entity	I-Entity	1237	1238	B	B	I-NP	NN	I-DNA	37	NMOD	I-DNA
T14	I-Entity	I-Entity	1239	1242	cis	cis	I-NP	NN	I-DNA	40	NMOD	I-DNA
T14	I-Entity	I-Entity	1242	1243	-	-	B-NP	HYPH	I-DNA	40	NMOD	I-DNA
T14	I-Entity	I-Entity	1243	1249	acting	act	I-NP	VBG	I-DNA	40	NMOD	I-DNA
T14	I-Entity	I-Entity	1250	1258	elements	element	I-NP	NNS	I-DNA	34	PMOD	I-DNA
O	O	O	1258	1259	.	.	O	.	O	11	P	O

O	O	O	1260	1278	Immunofluorescence	Immunofluorescence	B-NP	NN	O	2	NMOD	O
O	O	O	1279	1286	studies	study	I-NP	NNS	O	19	SUB	O
O	O	O	1287	1292	using	use	B-VP	VBG	O	2	NMOD	O
O	O	O	1293	1295	an	an	B-NP	DT	O	5	NMOD	O
O	O	O	1296	1298	Ab	Ab	I-NP	NN	O	3	OBJ	O
O	O	O	1299	1301	to	to	B-PP	TO	O	5	NMOD	O
O	O	O	1302	1305	the	the	B-NP	DT	O	12	NMOD	O
T10	B-Protein	B-Protein	1306	1310	RelA	RelA	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	1311	1312	(	(	O	(	I-protein	12	NMOD	I-protein
T11	B-Protein	B-Protein	1312	1315	p65	p65	B-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	1315	1316	)	)	O	)	I-protein	12	NMOD	I-protein
O	O	O	1317	1324	subunit	subunit	B-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	1325	1327	of	of	B-PP	IN	O	12	NMOD	O
T15	B-Entity	B-Entity	1328	1335	nuclear	nuclear	B-NP	JJ	B-protein	18	NMOD	B-protein
T15	I-Entity	I-Entity	1336	1342	factor	factor	I-NP	NN	I-protein	18	NMOD	I-protein
T15	I-Entity	I-Entity	1342	1343	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T15	I-Entity	I-Entity	1343	1348	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T15	I-Entity	I-Entity	1349	1350	B	B	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	1351	1359	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	O	1360	1364	that	that	B-SBAR	IN	O	19	VMOD	O
O	O	O	1365	1368	iNO	iNO	B-NP	NN	O	22	SUB	O
O	O	O	1369	1378	inhibited	inhibit	B-VP	VBD	O	20	SBAR	O
O	O	O	1379	1382	the	the	B-NP	DT	O	24	NMOD	O
O	O	O	1383	1393	activation	activation	I-NP	NN	O	22	OBJ	O
O	O	O	1394	1396	of	of	B-PP	IN	O	24	NMOD	O
T16	B-Entity	B-Entity	1397	1404	nuclear	nuclear	B-NP	JJ	B-protein	30	NMOD	B-protein
T16	I-Entity	I-Entity	1405	1411	factor	factor	I-NP	NN	I-protein	30	NMOD	I-protein
T16	I-Entity	I-Entity	1411	1412	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T16	I-Entity	I-Entity	1412	1417	kappa	kappa	I-NP	NN	I-protein	30	NMOD	I-protein
T16	I-Entity	I-Entity	1418	1419	B	B	I-NP	NN	I-protein	25	PMOD	I-protein
O	O	O	1419	1420	.	.	O	.	O	19	P	O

O	O	O	1421	1426	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1427	1434	studies	study	I-NP	NNS	O	3	SUB	O
O	O	O	1435	1443	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	1444	1448	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1449	1452	iNO	iNO	B-NP	NN	B-protein	6	SUB	B-protein
O	O	O	1453	1463	attenuates	attenuate	B-VP	VBZ	O	4	SBAR	O
T12	B-Protein	B-Protein	1464	1468	iNOS	iNOS	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	1469	1479	expression	expression	I-NP	NN	O	6	OBJ	O
O	O	O	1480	1482	in	in	B-PP	IN	O	8	NMOD	O
O	O	O	1483	1494	macrophages	macrophage	B-NP	NNS	B-cell_type	9	PMOD	B-cell_type
O	O	O	1495	1498	and	and	O	CC	O	6	VMOD	O
O	O	O	1499	1507	inhibits	inhibit	B-VP	VBZ	O	6	VMOD	O
O	O	O	1508	1516	monocyte	monocyte	B-NP	NN	O	14	NMOD	O
O	O	O	1517	1525	adhesion	adhesion	I-NP	NN	O	12	OBJ	O
O	O	O	1526	1528	to	to	B-PP	TO	O	14	NMOD	O
O	O	O	1529	1540	endothelial	endothelial	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	O	1541	1546	cells	cell	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	O	1546	1547	,	,	O	,	O	3	P	O
O	O	O	1548	1551	and	and	O	CC	O	3	VMOD	O
O	O	O	1552	1559	suggest	suggest	B-VP	VBP	O	3	VMOD	O
O	O	O	1560	1564	that	that	B-SBAR	IN	O	20	VMOD	O
O	O	O	1565	1577	endogenously	endogenously	B-NP	RB	O	23	AMOD	O
O	O	O	1578	1585	derived	derive	I-NP	VBN	O	24	NMOD	O
O	O	O	1586	1589	iNO	iNO	I-NP	NN	O	25	SUB	O
O	O	O	1590	1593	may	may	B-VP	MD	O	21	SBAR	O
O	O	O	1594	1596	be	be	I-VP	VB	O	25	VC	O
O	O	O	1597	1599	an	an	B-NP	DT	O	30	NMOD	O
O	O	O	1600	1609	important	important	I-NP	JJ	O	30	NMOD	O
O	O	O	1610	1624	autoregulatory	autoregulatory	I-NP	JJ	O	30	NMOD	O
O	O	O	1625	1634	inhibitor	inhibitor	I-NP	NN	O	26	PRD	O
O	O	O	1635	1637	of	of	B-PP	IN	O	30	NMOD	O
O	O	O	1638	1646	vascular	vascular	B-NP	JJ	O	33	NMOD	O
O	O	O	1647	1659	inflammation	inflammation	I-NP	NN	O	31	PMOD	O
O	O	O	1659	1660	.	.	O	.	O	3	P	O
